← All organizations

Histogen

For profitWebsite ↗

Also known as: Histogen

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Nov 10, 2021

Defunct as of Sep 18, 2023

Timeline

2000s

Jun 1, 2007
Histogen— Founded

2020s

Jan 29, 2020
Conatus Pharmaceuticals— Acquired
Sep 18, 2023
Histogen— Defunct

Drugs by trial phase (7 distinct, 25 trials)

Phase 2 (1 own, 4 via acquisition)

Phase 1 (2 own, 0 via acquisition)

Indications

Studied for

Subsidiaries (1 direct, 2 total across the full acquisition tree)

Recent trials (6)

NCT05082831Study directorPhase 1Nov 10, 2021
NCT05082831Lead sponsorPhase 1Nov 10, 2021
NCT04803227Lead sponsorPhase 1Mar 11, 2021
NCT04435847Lead sponsorPhase 1May 26, 2020
NCT03662854Lead sponsorPhase 1Jul 2, 2018
NCT01501617Lead sponsorPhase 1/Phase 2Dec 31, 2011

Details

Founded: San Diego, CA, US Jun 1, 2007
Last known activity: Nov 10, 2021